Avenue Therapeutics Ownership 2024 | Who Owns Avenue Therapeutics Now?
Institutional Ownership
1.12%
Insider Ownership
1.25%
Retail Ownership
97.63%
Institutional Holders
1.00
Avenue Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SHIKIAR ASSET MANAGEMENT INC | - | - | - | -25,000 | -100.00% | - | Sep 30, 2023 |
Avenue Therapeutics's largest institutional shareholder is SHIKIAR ASSET MANAGEMENT INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SHIKIAR ASSET MANAGEMENT INC | - | - | - | -25,000 | -100.00% | - | Sep 30, 2023 |
The largest Avenue Therapeutics shareholder by % of total assets is SHIKIAR ASSET MANAGEMENT INC. The company owns 0.00 shares of Avenue Therapeutics (ATXI), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SHIKIAR ASSET MANAGEMENT INC | - | - | - | -25,000 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Avenue Therapeutics's largest institutional buyer is SHIKIAR ASSET MANAGEMENT INC. The company purchased -25.00K stocks of ATXI, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SHIKIAR ASSET MANAGEMENT INC | - | - | - | -25,000 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Avenue Therapeutics's biggest institutional seller is SHIKIAR ASSET MANAGEMENT INC. The company sold -25.00K shares of ATXI, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SHIKIAR ASSET MANAGEMENT INC | - | - | - | -25,000 | -100.00% | - | Sep 30, 2023 |
Avenue Therapeutics's largest sold out institutional shareholder by shares sold is SHIKIAR ASSET MANAGEMENT INC, sold -25.00K shares, valued at -, as of undefined.
Avenue Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY COMMONWEALTH TRUST | 0.00% | 10,099 | - | - | Feb 29, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,234 | - | - | Mar 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.00% | 10,559 | - | - | Mar 31, 2024 |
GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 6,672 | - | - | Mar 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 340 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 82,446 | - | - | Feb 29, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 14,314 | - | - | Feb 29, 2024 |
GPS Funds I | 0.00% | 1,826 | - | - | Mar 31, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 913 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 125,030 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 52,160 | -411 | -0.78% | Feb 29, 2024 |
Calvert Variable Products, Inc. | 0.00% | 589 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 46,293 | -46,293 | -50.00% | Mar 31, 2024 |
SunAmerica Specialty Series | 0.00% | 55 | - | - | Apr 30, 2021 |
HC CAPITAL TRUST | 0.00% | 1,895 | - | - | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 1,400 | - | - | Mar 31, 2024 |
RUSSELL INVESTMENT CO | 0.00% | 12,160 | - | - | Jan 31, 2024 |
Investment Managers Series Trust II | 0.00% | 473 | - | - | Jan 31, 2024 |
NORTHERN FUNDS | 0.00% | 3,845 | - | - | Mar 28, 2024 |
PGIM ETF TRUST | 0.00% | 1,588 | - | - | Feb 29, 2024 |
OLD WESTBURY FUNDS INC | 0.00% | 3,118 | - | - | Jan 31, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 85,030 | - | - | Mar 31, 2024 |
Goldman Sachs ETF Trust | 0.00% | 1,697 | - | - | Feb 29, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,000 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 144 | - | - | Mar 31, 2024 |
MAINSTAY VP FUNDS TRUST | 0.00% | 1,400 | - | - | Mar 31, 2024 |
VALIC Co I | 0.00% | 3,163 | - | - | Feb 29, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 21,184 | - | - | Feb 29, 2024 |
TIAA-CREF FUNDS | 0.00% | 29,376 | - | - | Mar 31, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 491 | - | - | Feb 29, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 993 | - | - | Mar 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 852 | - | - | Jan 31, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 5,456 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,162 | - | - | Jan 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 421 | - | - | Feb 29, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 59 | - | - | Feb 29, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 721 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,678 | - | - | Mar 31, 2024 |
MAINSTAY FUNDS TRUST | 0.00% | 200 | - | - | Jan 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 975 | - | - | Dec 31, 2023 |
PACIFIC SELECT FUND | 0.00% | 2,937 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 7,710 | - | - | Mar 31, 2024 |
Bridge Builder Trust | 0.00% | 2,010 | - | - | Mar 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 806 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 821 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 250 | - | - | Mar 31, 2024 |
Avenue Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 10.10K shares, compromising 0.00% of its total assets.
Avenue Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 23 | 1 | - |
31 Mar, 23 | 1 | - |
30 Jun, 22 | 16 | 14.29% |
31 Mar, 22 | 14 | -6.67% |
31 Dec, 21 | 15 | -16.67% |
30 Sep, 21 | 18 | -28.00% |
30 Jun, 21 | 25 | -26.47% |
31 Mar, 21 | 34 | -2.86% |
31 Dec, 20 | 35 | 6.06% |
30 Sep, 20 | 33 | -8.33% |
30 Jun, 20 | 36 | 80.00% |
31 Mar, 20 | 20 | 33.33% |
31 Dec, 19 | 15 | - |
30 Sep, 19 | 15 | 25.00% |
30 Jun, 19 | 12 | -7.69% |
31 Mar, 19 | 13 | 85.71% |
31 Dec, 18 | 7 | - |
30 Sep, 18 | 7 | - |
30 Jun, 18 | 7 | 40.00% |
31 Mar, 18 | 5 | - |
31 Dec, 17 | 5 | -37.50% |
30 Sep, 17 | 8 | 300.00% |
30 Jun, 17 | 2 | - |
As of 30 Jun 23, 1 institutions are holding Avenue Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 23 | 25,000 | -37.49% |
31 Mar, 23 | 39,992 | - |
30 Jun, 22 | 673,937 | -35.25% |
31 Mar, 22 | 1,040,903 | -55.93% |
31 Dec, 21 | 2,361,894 | 116.90% |
30 Sep, 21 | 1,088,937 | -5.29% |
30 Jun, 21 | 1,149,746 | -37.70% |
31 Mar, 21 | 1,845,619 | -10.20% |
31 Dec, 20 | 2,055,305 | -25.11% |
30 Sep, 20 | 2,744,268 | 5.03% |
30 Jun, 20 | 2,612,751 | 33.02% |
31 Mar, 20 | 1,964,145 | 25.08% |
31 Dec, 19 | 1,570,283 | 8.09% |
30 Sep, 19 | 1,452,790 | 6.54% |
30 Jun, 19 | 1,363,573 | 17.61% |
31 Mar, 19 | 1,159,432 | 68.47% |
31 Dec, 18 | 688,200 | 212.33% |
30 Sep, 18 | 220,347 | -0.01% |
30 Jun, 18 | 220,363 | 11.61% |
31 Mar, 18 | 197,434 | 38.61% |
31 Dec, 17 | 142,439 | 2.28% |
30 Sep, 17 | 139,259 | 387.09% |
30 Jun, 17 | 28,590 | - |
Avenue Therapeutics (ATXI) has 25.00K shares outstanding as of 30 Jun 23, down -37.49% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 23 | 1.12% | 34.79% |
31 Mar, 23 | 1.80% | - |
30 Jun, 22 | 3.08% | 12.46% |
31 Mar, 22 | 4.97% | 2.44% |
31 Dec, 21 | 14.27% | 33.26% |
30 Sep, 21 | 6.55% | 13.58% |
30 Jun, 21 | 6.94% | 5.59% |
31 Mar, 21 | 11.15% | 7.23% |
31 Dec, 20 | 12.41% | 4.50% |
30 Sep, 20 | 16.61% | 6.60% |
30 Jun, 20 | 15.86% | 11.16% |
31 Mar, 20 | 11.92% | 13.12% |
31 Dec, 19 | 9.53% | 12.11% |
30 Sep, 19 | 8.87% | 12.70% |
30 Jun, 19 | 8.36% | 11.74% |
31 Mar, 19 | 8.44% | 18.67% |
31 Dec, 18 | 6.72% | 146.75% |
30 Sep, 18 | 2.14% | 46.32% |
30 Jun, 18 | 2.15% | 56.24% |
31 Mar, 18 | 1.95% | 95.74% |
31 Dec, 17 | 1.43% | 73.21% |
30 Sep, 17 | 1.40% | 204.60% |
30 Jun, 17 | 0.83% | - |
As of 30 Jun 23, Avenue Therapeutics is held by 1.12% institutional shareholders, representing a 34.79% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 23 | 1 | - |
31 Mar, 23 | 1 | - |
30 Jun, 22 | 6 | -25.00% |
31 Mar, 22 | 8 | 14.29% |
31 Dec, 21 | 7 | -22.22% |
30 Sep, 21 | 9 | -30.77% |
30 Jun, 21 | 13 | -13.33% |
31 Mar, 21 | 15 | -31.82% |
31 Dec, 20 | 22 | 46.67% |
30 Sep, 20 | 15 | -51.61% |
30 Jun, 20 | 31 | 93.75% |
31 Mar, 20 | 16 | 77.78% |
31 Dec, 19 | 9 | 12.50% |
30 Sep, 19 | 8 | 33.33% |
30 Jun, 19 | 6 | -33.33% |
31 Mar, 19 | 9 | 125.00% |
31 Dec, 18 | 4 | 33.33% |
30 Sep, 18 | 3 | -40.00% |
30 Jun, 18 | 5 | 66.67% |
31 Mar, 18 | 3 | -40.00% |
31 Dec, 17 | 5 | -28.57% |
30 Sep, 17 | 7 | 250.00% |
30 Jun, 17 | 2 | - |
1 institutional shareholders have increased their position in ATXI stock as of 30 Jun 23 compared to 1 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 23 | - | - |
31 Mar, 23 | - | - |
30 Jun, 22 | 7 | 133.33% |
31 Mar, 22 | 3 | -40.00% |
31 Dec, 21 | 5 | - |
30 Sep, 21 | 5 | -54.55% |
30 Jun, 21 | 11 | 22.22% |
31 Mar, 21 | 9 | 50.00% |
31 Dec, 20 | 6 | -53.85% |
30 Sep, 20 | 13 | 550.00% |
30 Jun, 20 | 2 | 100.00% |
31 Mar, 20 | 1 | -75.00% |
31 Dec, 19 | 4 | - |
30 Sep, 19 | 4 | 33.33% |
30 Jun, 19 | 3 | 50.00% |
31 Mar, 19 | 2 | - |
31 Dec, 18 | 2 | - |
30 Sep, 18 | 2 | 100.00% |
30 Jun, 18 | 1 | -50.00% |
31 Mar, 18 | 2 | - |
31 Dec, 17 | - | -100.00% |
30 Sep, 17 | 1 | - |
30 Jun, 17 | - | - |
- institutional shareholders have reduced their position in ATXI stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 23 | 1 | - | 25,000 | -37.49% | 1.12% | 34.79% | 1 | - | - | - |
31 Mar, 23 | 1 | - | 39,992 | - | 1.80% | - | 1 | - | - | - |
30 Jun, 22 | 16 | 14.29% | 673,937 | -35.25% | 3.08% | 12.46% | 6 | -25.00% | 7 | 133.33% |
31 Mar, 22 | 14 | -6.67% | 1,040,903 | -55.93% | 4.97% | 2.44% | 8 | 14.29% | 3 | -40.00% |
31 Dec, 21 | 15 | -16.67% | 2,361,894 | 116.90% | 14.27% | 33.26% | 7 | -22.22% | 5 | - |
30 Sep, 21 | 18 | -28.00% | 1,088,937 | -5.29% | 6.55% | 13.58% | 9 | -30.77% | 5 | -54.55% |
30 Jun, 21 | 25 | -26.47% | 1,149,746 | -37.70% | 6.94% | 5.59% | 13 | -13.33% | 11 | 22.22% |
31 Mar, 21 | 34 | -2.86% | 1,845,619 | -10.20% | 11.15% | 7.23% | 15 | -31.82% | 9 | 50.00% |
31 Dec, 20 | 35 | 6.06% | 2,055,305 | -25.11% | 12.41% | 4.50% | 22 | 46.67% | 6 | -53.85% |
30 Sep, 20 | 33 | -8.33% | 2,744,268 | 5.03% | 16.61% | 6.60% | 15 | -51.61% | 13 | 550.00% |
30 Jun, 20 | 36 | 80.00% | 2,612,751 | 33.02% | 15.86% | 11.16% | 31 | 93.75% | 2 | 100.00% |
31 Mar, 20 | 20 | 33.33% | 1,964,145 | 25.08% | 11.92% | 13.12% | 16 | 77.78% | 1 | -75.00% |
31 Dec, 19 | 15 | - | 1,570,283 | 8.09% | 9.53% | 12.11% | 9 | 12.50% | 4 | - |
30 Sep, 19 | 15 | 25.00% | 1,452,790 | 6.54% | 8.87% | 12.70% | 8 | 33.33% | 4 | 33.33% |
30 Jun, 19 | 12 | -7.69% | 1,363,573 | 17.61% | 8.36% | 11.74% | 6 | -33.33% | 3 | 50.00% |
31 Mar, 19 | 13 | 85.71% | 1,159,432 | 68.47% | 8.44% | 18.67% | 9 | 125.00% | 2 | - |
31 Dec, 18 | 7 | - | 688,200 | 212.33% | 6.72% | 146.75% | 4 | 33.33% | 2 | - |
30 Sep, 18 | 7 | - | 220,347 | -0.01% | 2.14% | 46.32% | 3 | -40.00% | 2 | 100.00% |
30 Jun, 18 | 7 | 40.00% | 220,363 | 11.61% | 2.15% | 56.24% | 5 | 66.67% | 1 | -50.00% |
31 Mar, 18 | 5 | - | 197,434 | 38.61% | 1.95% | 95.74% | 3 | -40.00% | 2 | - |
31 Dec, 17 | 5 | -37.50% | 142,439 | 2.28% | 1.43% | 73.21% | 5 | -28.57% | - | -100.00% |
30 Sep, 17 | 8 | 300.00% | 139,259 | 387.09% | 1.40% | 204.60% | 7 | 250.00% | 1 | - |
30 Jun, 17 | 2 | - | 28,590 | - | 0.83% | - | 2 | - | - | - |
Avenue Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Avenue Therapeutics's stock was made by Davidow Robert L on Dec 13 2023, selling 264,000 shares at $0.14 per share (valued at $36.96K). The last insider buy of ATXI was made by ROSENWALD LINDSAY A MD on Sep 12 2023, buying 348,675 shares at $0.72 per share (worth $251.05K).
Avenue Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 1 | - | - |
Q1 2024 | 1 | - | - |
Q4 2023 | - | 7 | - |
Q3 2023 | 2 | - | - |
Q2 2023 | 7 | - | - |
Q1 2023 | 2 | - | - |
Q4 2022 | 1 | 1 | 100.00% |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q4 2021 | 7 | - | - |
Q3 2021 | - | 1 | - |
Q2 2021 | 1 | - | - |
Q3 2020 | - | 1 | - |
Q2 2020 | 2 | - | - |
Q1 2020 | 9 | - | - |
Q3 2019 | 3 | 2 | 150.00% |
Q2 2019 | 5 | - | - |
Q1 2019 | 8 | 1 | 800.00% |
Q4 2018 | 2 | - | - |
Q3 2018 | 9 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Avenue Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | 6 | - |
Q3 2023 | 2 | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | 1 | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | 1 | - |
Q2 2021 | 1 | - | - |
Q3 2020 | - | 1 | - |
Q2 2020 | - | - | - |
Q1 2020 | 7 | - | - |
Q3 2019 | 1 | 2 | 50.00% |
Q2 2019 | 3 | - | - |
Q1 2019 | 8 | - | - |
Q4 2018 | 2 | - | - |
Q3 2018 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Avenue Therapeutics's stocks.
Avenue Therapeutics Peer Ownership
Ticker | Company |
---|---|
BDRX | Biodexa Pharmaceuticals Plc |
HOTH | Hoth Therapeutics, Inc. |
CFRX | ContraFect Corporation |
CNSP | CNS Pharmaceuticals, Inc. |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
VRAX | Virax Biolabs Group Limited |
ALLR | Allarity Therapeutics, Inc. |
NRBO | NeuroBo Pharmaceuticals, Inc. |
WINT | Windtree Therapeutics, Inc. |
PALI | Palisade Bio, Inc. |
ATXI Ownership FAQ
Who Owns Avenue Therapeutics?
Avenue Therapeutics is owned by institutional shareholders (1.12%), insiders (1.25%), and public (97.63%). The largest institutional shareholder of Avenue Therapeutics is SHIKIAR ASSET MANAGEMENT INC (0% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.00% of total shares).
Who are the major institutional shareholders of Avenue Therapeutics?
Avenue Therapeutics's major institutional shareholders are SHIKIAR ASSET MANAGEMENT INC. The top five shareholders own together 0% of the company's share outstanding.
How many Avenue Therapeutics shareholders are there?
As of Jun 2023, there are 1 institutional shareholders of Avenue Therapeutics.
What percentage of Avenue Therapeutics is owned by SHIKIAR ASSET MANAGEMENT INC?
SHIKIAR ASSET MANAGEMENT INC owns 0 shares of Avenue Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).